Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 بازدیدها
• 07/18/23
0
0
جاسازی کنید
administrator
مشترکین
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
SORT BY-
نظرات برتر
-
آخرین نظرات